APA (7th ed.) Citation

Yu, J., Powers III, J. H., Vallo, D., Falloon, J., & Powers, J. H. 3. (2020). Evaluation of Efficacy Endpoints for a Phase IIb Study of a Respiratory Syncytial Virus Vaccine in Older Adults Using Patient-Reported Outcomes With Laboratory Confirmation. Value in Health, 23(2), 227. https://doi.org/10.1016/j.jval.2019.09.2747

Chicago Style (17th ed.) Citation

Yu, Jing, John H. Powers III, David Vallo, Judith Falloon, and John H 3rd Powers. "Evaluation of Efficacy Endpoints for a Phase IIb Study of a Respiratory Syncytial Virus Vaccine in Older Adults Using Patient-Reported Outcomes With Laboratory Confirmation." Value in Health 23, no. 2 (2020): 227. https://doi.org/10.1016/j.jval.2019.09.2747.

MLA (9th ed.) Citation

Yu, Jing, et al. "Evaluation of Efficacy Endpoints for a Phase IIb Study of a Respiratory Syncytial Virus Vaccine in Older Adults Using Patient-Reported Outcomes With Laboratory Confirmation." Value in Health, vol. 23, no. 2, 2020, p. 227, https://doi.org/10.1016/j.jval.2019.09.2747.